Now Australia's Biggest Toy Shop

Shop over 1.5 Million Toys in our Huge New Range

Current News in Cardiology

Product Details

Table of Contents

Atrial Fibrillation and Atrial Flutter.- Anti-arrhythmic Drugs in Atrial Fibrillation: Historical Perspectives and New Developments.- "Pill-in-the-Pocket" Approach.- Lone Atrial Fibrillation: Prophylactic Anti-arrhythmic Treatment.- Radiofrequency Ablation of Atrial Fibrillation and Atrial Flutter: Who and When?.- Cryocatheter Ablation for Atrial Flutter.- Clinical Profile, Electrophysiological Characteristics, and Outcome after Radiofrequency Catheter Ablation of Atypical Atrial Flutter.- The Impact of New Imaging, Mapping and Energy Delivery Technology on the Current Approach to Ablation of Atrial Fibrillation.- Trigger vs Substrate Ablation for the Treatment of Atrial Fibrillation.- Complications of Atrial Fibrillation Ablation: How To Prevent Them.- Pacing in Atrial Fibrillation: Is It Still Viable?.- Traditional or Device Approach for the Management of Atrial Fibrillation in Patients with Heart Failure.- Conversion of Persistent Atrial Fibrillation to Sinus Rhythm by DC Shock: Is It Still in Use Two Years After AFFIRM?.- Lone Atrial Fibrillation and Sports Activities.- Heart Failure.- Heart-Failure Management: Focus on Heart-Failure Practice Guidelines.- Determination of Left Ventricular Contractile Reserve by Dobutamine Stress Echocardiography To Predict the Response to CRT.- Focus on Optimization of Cardiac Resynchronization Therapy Techniques.- Evaluation of the Clinical State of Cardiac Resynchronization Therapy Patients by Continuous Heart-Failure Monitoring.- Predicting Heart Failure Events in CRT Patients: Future Challenges.- Use of Fluid Accumulation Monitoring in HF Patients.- Syncope.- Performing Carotid Sinus Massage.- Performing Tilt Testing and Physical Countermaneuvers Training.- Implanting a Loop Recorder.- Sudden Death.- Noninvasive Sudden Death Risk Stratification: Heart Rate Variability and Turbulence, and QT Dynamicity.- Noninvasive Risk Stratification of Sudden Death: T-Wave Alternans.- Risk Stratification for Sudden Death in Hypertrophic Cardiomyopathy.- Managing Hypertrophic Cardiomyopathy: Screening in Young Subjects.- The Prevention of Sudden Death: New Perspectives.- Which Patient and when Should Receive an ICD? Evolving New Indications on the Horizon.- Implantable Cardiac Defibrillators: Is Defibrillation Threshold Testing Still Necessary in all Patients?.- Current Practice in Italy of VF Testing at Implant: What Do We Know and Where Do We Go From Here?.- How To Choose Between Single-Chamber and Dual-Chamber ICD.- Which Patients Should Receive Dual Defibrillators? Results of DATAS.- Prevention of Sudden Death in Patients with Genetic Arrhythmias.- Cost-Effectiveness of ICD Therapy in the Prevention of Sudden Death in CAD and/or HF Patients.- Cardiac Pacing.- Hemodynamic Impact of Right Ventricular Pacing.- Hemodynamics in Standard Cardiac Pacing.- Hemodynamic Assessment with an Implanted Pacing Device.- Hemodynamic Optimization of Pacing Configuration in Bradyarrhythmias.- Applications of TVI Sensing in Cardiac Stimulation.- The Ideal Pacemaker for Complete AV Block.- The Ideal Pacemaker for Elderly Patients.- Electrocardiography.- Update on ACC/ESC Criteria for Acute ST Elevation Myocardial Infarction.- ECG-MRI based Localization of Myocardial Infarction.- Electrocardiographic Predictors of Arrhythmias In CCU Patients.- The Routine ECG as a Marker of Sudden Cardiac Death.- Acute Coronary Syndromes.- International Guidelines on Acute Coronary Syndrome: Practical Application and Current News in Cardiology.- Is There a Limit to PTCA in Elderly Patients?.- When Should Patients with Ischemic Mitral Regurgitation Undergo Cardiac Surgery?.- Minimally Invasive Techniques in Cardiac Surgery: An Opportunity for All Patients?.- Global Cardiovascular Risk Prevention.- Cardiovascular Risk Management: An Overview.- Is Arterial Pressure Self-Measurement Better Than Ambulatory 24-Hour Pressure Monitoring?.- Role of Angiotensin-Receptor Blockers in the Prevention of Cardiovascular Risk: Clinical Guidelines.- New Evidence about the Beneficial Effects of Angiotensin-Receptor Blockers on the Heart and the Kidney.- Lercanidipine, Enalapril, and Their Combination in the Treatment of Elderly Hypertensive Patients.

Ask a Question About this Product More...
Write your question below:
Look for similar items by category
Home » Books » Science » Medicine » Cardiology
This title is unavailable for purchase as none of our regular suppliers have stock available. If you are the publisher, author or distributor for this item, please visit this link.
Back to top